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Abstract: The introduction of hybrid materials in regenerative medicine has solved some problems related to the 
mechanical and bioactive properties of biomaterials. Calcium phosphates and their derivatives have provided the basis 
for inorganic components, thanks to their good bioactivity, especially in bone regeneration. When mixed with 
biodegradable polymers, the result is a synergic association that mimics the composition of many tissues of the human 
body and, additionally, exhibits suitable mechanical properties. Together with the development of nanotechnology and 
new synthesis methods, hybrids offer a promising option for the development of a third or fourth generation of 
smart biomaterials and scaffolds to guide the regeneration of natural tissues, with an optimum efficiency/cost ratio. 
Their potential bioactivity, as well as other valuable features of hybrids, open promising new pathways for their use 
in bone regeneration and other tissue repair therapies. This review provides a comprehensive overview of the 
different hybrid organic-inorganic scaffolding bio- materials developed so far for regenerative therapies, especially 
in bone. It also looks at the potential for research into hybrid materials for other, softer tissues, which is still at an 
initial stage, but with very promising results. 
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1. INTRODUCTION 
Many strategies involving composites have been implemented since the 80s, particularly for second generation 
biomaterials [1, 2]. The development of hybrid materials (i.e. composites whose components demonstrate interactions at 
the molecular or nanometric level) in regenerative medicine accomplishes several requirements that pure materials 
cannot fulfill, especially those linked to mechanical issues. The possibility of introducing the inherent bioactivity of calcium 
phosphates (CaP) is a bonus that makes any composite involving CaP very interesting. 
The main aim of composite materials in therapies is to obtain templates which have suitable mechanical properties, 
as well as bioactivity. Nowadays, their potential use can be extended to almost all human tissues. However, the main field 
whose requirements have triggered the development of composite and hybrid materials has been bone regeneration, as a 
way to develop a third and fourth generation of smart biomaterials and scaffolds to guide the regeneration of natural 
tissue [1, 3] . The use of hybrids in other branches of regeneration is an easy step forward thanks to their potential 
bioactivity and versatile features. In this review, we will describe recent developments using hybrid inorganic/organic 
materials which have already been developed for tissue regeneration. In addition, we discuss carbon nanotubes (CNT) and 
their derivatives, as they have gained popularity in several applications in the field of tissue regeneration, in particular 
nerve and muscle regeneration. Even though carbon nanotubes are not inorganic materials, they present some similar 
properties to inorganic materials, and we con- sider that they also deserve our attention. 
In today’s biomaterials for tissue regeneration, the trend is to be able to mimic the natural extracellular matrix (ECM) 
with its corresponding features, functions and hierarchical organization [3]. Bone, for example, is the result of an 
osteoblast-mediated mineralized ECM or osteoid, whose Young modulus goes from 27 kPa to 1 GPa, referred to as final 
rigid bone [4]. These values have generated a controversy in bone regeneration: should implanted grafts be as rigid as 
bone, or should high stiffness be relinquished for the final result? In addition, mature bone is made up of different 
components, each with a specific role within a comprehensive function. Function strongly depends on architecture, which 
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is why there is no universal bone substitute, but instead specific designs for particular applications. 
 
2. INTRODUCTION TO BONE TISSUE 
Basically, bone tissue is a strong and tough connective tissue that supports and protects the rest of the internal 
organs, allows the body to move, offers an ideal environment for blood cell formation, and acts as a store for salts 
(especially calcium phosphates), among other functions [5]. Bone, as a hybrid natural construct, is an inspiring material that 
presents a complex and highly hierarchical organized structure [6]. Morphologically, it can be subdivided into two distinct 
types according to porosity and unit microstructure: the cortical bone (also known as compact bone) and the trabecular 
bone (also called cancellous or spongy bone) [7, 8]. The cortical bone is distinguished by its high density (low porosity and 
void spaces) and represents the higher percentage of the total bone mass of an individual (around 80%). It typically 
forms the outer shell of most bones and supports the mechanical properties of the skeleton. The trabecular bone is 
defined by its low density and accounts for the other 20% of the total bone mass of an adult. It possesses a significantly 
higher surface area, and its high porosity allows room for blood vessels and bone marrow. 
 
Fig. (1). Hierarchical structural organization of bone. (scheme reprinted from [7] with permission). 
 
Cortical and trabecular bones are both made of nearly the same organic and inorganic components (Fig. 1). The 
combination of these two phases with different natures makes bone a composite tissue. Each component phase contributes 
to the unique mechanical properties of bone and depends on the structural organization of each phase [7]. Generally, it 
is commonly accepted that the organic part provides elasticity and flexibility to the bone, whereas the inorganic one provides 
rigidity and load-bearing strength [6]. The major organic constituents are collagens organized in fibril bundles that form 
a 3D nanoscaled collageneous matrix network [7, 9]. Proteoglycans, noncollageneous macromolecules (other proteins like 
osteocalcin, osteopontin, bone morphogenetic protein-2 (BMP-2), etc) [6] and cells complete the organic composition. The 
inorganic constituent is mainly formed by carbonated hydroxyapatite, a calcium phosphate mineral with low crystallinity and 
some amounts of carbonate that epitaxially nucleates and grows along the collagen fibrils. 
 
Fig. (2). Dynamic dependence between the various features of 3D scaffolds on cells and involved in the regulation of a material’s 
biological performance. (scheme adapted from [13]). 
 
3. SCAFFOLD PROPERTIES AND THEIR  EFFECT ON CELLULAR BEHAVIOR 
Adhesion, proliferation and differentiation of cells cultured on a scaffold constitute the basis of tissue engineering 
approaches. It is well known that cell-cell interactions direct cellular activity towards these behaviors and contribute to 
determining the fate of uncommitted stem cells [10, 11]. In addition, the material properties also directly affect cell 
function; in fact, these can be efficiently used to control cellular processes through three-dimensional chemical and physical 
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guidance. The key design factors in developing a biomaterial aimed at triggering specific cellular responses are its chemical 
and mechanical surface properties and its architecture (Fig. 2). Together, all these material properties coordinate the 
interplay be- tween intrinsic and extrinsic determinants of stem cell fate to pro- duce a desired phenotype [12, 13]. 
3.1. Scaffold Architecture 
The choice of a suitable fabrication technique to produce 3D structures is a significant hurdle for the improvement 
of tissue engineering treatments [14]. The architecture of the fabricated material should, in fact, not only have suitable 
mechanical properties, but also enable an optimal mass and fluid transport through the whole template [15]. In other 
words, the substrate prepared should exhibit a suitable porosity to ensure the efficient colonization of the material by 
cells, enable the supply of nutrients and oxygen, ensure the evacuation of detritus, and support the invasion of blood 
vessels. All these phenomena will contribute to the performance of the material and, ultimately, to the formation of fully 
functional and healthy bone. Appropriate porosity is thus a crucial requirement for bone regeneration [16]. 
As seen in (Fig. 3), materials can be shaped into different forms depending on the processing techniques used to 
fabricate scaffolds (foaming [17, 18], sintering [19], salt leaching [20], rapid- prototyping [21], electrospinning [22], 
etc). Each technique results in materials with specific pore size and interconnectivity, which can be controlled by varying 
the experimental parameters [23]. Porosity can be considered at three levels: macro-, meso- and microporosity. 
Macroporosity refers to pores having a width larger than 50 nm, mesoporosity to those between 2 and 50 nm, and 
microporosity to those with a width smaller than 2 nm [24]. 
Macroporosity is considered the most relevant factor that influences cell behavior, bone growth and vascularization. For 
example, Valerio et al. demonstrated that bioactive glass macroporous structures with pores ranging from 100 µm to 500 
µm (prepared by the sol-gel method and foaming technique) support cell migration to- wards the inside of the scaffold 
[25]. Sepulveda et al. and Xynos et al. also showed that foams with large pores (diameters between 10 and 500 µm) enhanced 
cellular differentiation and proliferation, as well as bone formation and vascularization [26, 27]. According to Hulbert et 
al., the minimum size requirement for macropores is around 100 µm [28]. In their study in dogs, they showed that samples 
with pores between 75 µm to 100 µm induced only little bone ingrowth, whereas samples with pores ranging from 100 µm to 
150 µm in size promoted better bone ingrowth and the formation of calcified tissue. Samples with pores smaller than 75 
µm were infiltrated by fibrous connective tissue only. 
 
 
 
 
Fig. (3). Examples of hybrid scaffolds prepared using different process techniques (from left to right): foams, monoliths, fibers. (picture 
a is adapted from [17] and from [18] with permissions, picture b from [19] with permission, picture c from the author’s own propriety). 
 
The samples with the largest pores in the study (150-200 µm) exhibited the best results in terms of calcification, 
vascularization and the presence of unmineralized bone within the pores. They justified the relevance of their results by 
correlating their observations with the diameter of the normal harversian system (100-200 µm). This showed the critical 
importance of macroporosity on cellular response in terms of osteo- and angiogenesis. However, depending on the testing 
conditions (load bearing or non-load bearing conditions), the critical pore size mentioned by Hulbert and coworkers appears 
not to be universal [29, 30]. Also, results differ between in vitro and in vivo assays, which make it difficult to define 
precise criteria for the size of macropores. In in vitro conditions, a low porosity can stimulate osteogenesis by 
suppressing cell proliferation and forcing cell aggregation, while in in vivo conditions, a higher porosity and pore size 
promoted better bone ingrowth due to good vascularization and oxygenation, thus favoring osteogenesis [15]. Moreover, the 
optimal or range of optimal pore size required for bone regeneration has been suggested to be dependent on each distinct 
cell type, and has also been shown to possess an upper limit of efficient functionality [31]. Finally, the interconnectivity 
of pores is essential for bone regeneration as it enables the infiltration of bone, the development of an efficient network 
a) b) c) 
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of blood vessels, and the promotion of cell- cell interactions [16, 25, 32]. 
On the other hand, meso- and microporosity also affect cellular response. The presence of these very small pores 
increases the surface area of the scaffold, promotes the adsorption of biological metabolites such as proteins, and 
enhances cell adhesion [33, 34]. The roughness created by these small pores can favor the anchorage of cells, and improves 
the proliferation and differentiation of bone cell lineage [34-36]. In parallel, in the case of biodegradable materials, it 
contributes to better ion exchange and bone-like apatite formation by the dissolution and re-precipitation process [37]. 
Simon et al. showed that geometrical parameters (pore size and the spatial arrangement of pores) affect the pattern of 
bone ingrowth [38]. The ability to vary and control the level of the three different types of porosity (i.e. meso-, micro- 
and macroporosity) is, therefore, a key factor in the development of scaffolds for bone tissue engineering. As previously 
explained, the sol-gel technology ap- pears to be a noteworthy method of tailoring cellular response by varying porosity, 
because it enables the control of the macroporosity of materials by using different fabrication methods to tune their 
texture at the meso- and micro levels [27, 39]. It should be noticed, however, that the porosity of the material always has 
to be a com- promise between biological behavior and mechanical properties, as a too high void volume may provide good 
vascularization and osteointegration, but significantly decreases the scaffold’s resistance to mechanical failure [40]. 
Another predominant research topic regarding the optimization of bone tissue repair is the ability to control cell-ECM 
interactions and to optimize cellular responses by producing materials with features tailored at the micro- and nanoscales. 
If roughness can be achieved through the fabrication of meso-microporous scaffolds, it can also be tailored by engineering 
the surface of materials using various techniques. The texturing and patterning of a material’s surface [41] can be 
performed using blasting [42], electropolishing [43], chemical treatments [44], lithography [45],plasma treatment [46] 
and focused ion beam [47], among other methods. It is well known that micro- and nanofeatures (roughness, for example) 
created on the surface positively affect cellular response (adhesion, detachment, proliferation, differentiation, 
spreading) compared to materials prepared with a smooth topography [43, 48]. Materials with nanofeatures are even 
thought to be more suitable than ones with microfeatures because they may be more biomimetic, and are consequently 
better at guiding cell behavior [49]. 
The base membranes of various tissues are composed of complex mixtures of nanoscale pits, pores, striations, 
particles, fibers and protrusions [48]. Based on a study conducted by Palin et al., the replication of nanoscale bone roughness 
on material surfaces indeed induces greater bone-forming cell adhesion and proliferation [50]. Other researchers have 
also shown that, for some materials, the smaller the nanofeatures, the better the cell adhesion and differentiation [51-
54]. However, it is difficult to establish a limit range of nanotopographic scale, in which bone regeneration is positively 
affected due to the diversity in topographic characteristics associ- ated to the different studies mentioned above (size, 
uniformity and shape). What is clear is that nanotopography controls cell behavior through the regulation of focal adhesion 
formation and cytoskeleton contractility, and activation of processes taking place at the sub-cell level (gene upregulation, 
cell signaling, cell metabolism) [45, 49, 54]. 
However, the physical surface patterning or texturing approach is not only used to modify the nanotopography of a 
material in terms of depth, pattern size or shape. It also enables the control of the anisotropy of a material’s surface, a 
property to which cells are highly sensitive too. Cells cultured on grooved substrates, for ex- ample, elongate and align 
in the direction of the groove [55, 56] (Fig. 4a). 
 
 
Fig. (4). Examples of morphology of cells cultured on a) tissue culture plate, e.g, not patterned or textured surface b) grooved substrate 
and c) aligned electrospun fibers. Arrows symbolize the direction of the anisotropy. (picture a is adapted from [57], picture b from [55] 
and picture c from [59] with permissions). 
The degree of alignment seems to be directly related to the depth of the grooves [56, 57], which demonstrates once 
again the importance of the roughness and the interplay of various physical factors for cellular activity. The spatial 
arrangement of fibers produced by electrospinning also induced similar responses [57, 58]. When cultured on aligned 
fibrous mats, cells oriented them- selves in the direction of the anisotropy (Fig. 4b) [55]. In contrast, on non-woven mats, 
cells spread following the multi-directions of the random fiber organization. In addition to this physical guidance, electrospun 
fibers present numerous particular advantages for bone tissue engineering (Fig. 4c) [59]. 
In summary, material properties directly influence bone formation in tissue engineering. Both physical and chemical cues 
play a role in the targeting of specific cellular responses required for the regeneration of a fully healthy functional bone 
(osteo- and angiogenesis). The choice of material constituents, the nature of the functional groups present at the material 
surface, the stiffness, rough- ness, nanofeatures and topography, among others, are many of the parameters that influence 
the mechanism. It is, however, difficult to investigate the role of each factor in an independent manner, as all of them are 
related. What is clear, though, is that bone formation is the result of a dynamic dependence between numerous properties, 
and that alongside cell-cell interactions and external mechanical stimulus, cell-biomaterial interactions account for an 
essential part of the regeneration process. Given the diversity of the materials currently produced, it is necessary to 
specify that each material possesses a unique combination of properties, and that each tem- plate will require specific 
improvements in order to achieve the proper biological performance. This should be achievable by finding a good 
compromise between all the criteria that the ideal scaf- fold should fulfill (mechanical properties, biological response, 
sterilizability, etc). Up to now, no ideal material has been developed – even though some are promising – and the design of 
biomaterials remains a challenging field of research with many and various development perspectives. 
 
3.2. Scaffold Surface Chemical Properties 
Scaffold surface chemical properties depend on the compounds selected to prepare the material (composition), the 
processing method, and an eventual functionalization step that can be per- formed on the surface after fabrication. Each 
biomaterial therefore possesses specific surface properties, such as for example wettability, electric charge, protein 
adsorption ability and bioactivity, which regulate the biological performance of the scaffold. One of the factors that can be 
considered to explain these differences in properties and in cellular response induced by the material is the nature of the 
functional groups present on its surface [60]. Hence, Lee et al. demonstrated that the functionalization of polyethylene 
substrates with different organic functional groups (COOH, CH2OH, CONH2, CH2NH2) resulted in a better cellular adhesion 
[61]. This was explained by a better wettability of the functional groups on grafted surfaces in comparison to non-grafted 
ones. They also showed that the chemistry of the functional groups itself was important, as it modifies the electric 
charge of the polymeric surface. Negatively charged substrates showed poor cell adhesion, whereas the positive ones 
exhibited the best. On neutral surfaces (-CH2OH and CONH2 groups), cell adhered better on hydroxyl-grafted substrates, 
possibly because of specific hydrogen bonding created between the surface hydroxyl groups of the polymer and the 
polar groups of the cell surfaces [62, 63]. However, the adhesion was still lower than on positively charged materials. 
Cell replication followed the same tendency as the cell adhesion assay: the more hydrophilic the material, the better the 
proliferation. Finally, it was demonstrated that substrates inducing the best proliferation were not necessarily those with 
the best cellular spreading. Indeed, cells spread significantly on the neutral surfaces, despite proliferating less than on 
the positively charged surfaces. The authors suggested that the compatibility between the cells and the surface chemistry 
plays a direct role in cellular spreading. Other research groups also described the general observations made by Lee et al. 
and gave further evidence that the nature of functional groups can also trigger osteoblastic differentiation [64, 65]. 
Other studies reported in the literature shows, moreover, that cell behavior can be influenced by these functional 
groups in an indirect manner: the surface properties that functional groups pro- vide to the material affect protein 
adsorption and, consequently, the cellular response [66-68]. Arima et. al. examined the kinetics of protein adsorption 
on materials having different functional groups and identified a correlation with cell adhesion [69]. Results showed that, 
depending on the chemistry of the functional groups exposed at the materials’ surfaces, non cell-adhesive proteins such 
as bovine serum albumin (BSA) previously adsorbed on self-assembled monolayers of alkanethiols (SAMs) were more or 
less rapidly replaced by cell-adhesive proteins  (fibronectin, vitronectin, etc). This induced difference in cell adhesion: 
SAMs terminated with COOH groups supported a better cell adhesion than ones having NH2 groups. This was explained 
by the slower protein displacement process in NH2-terminated materials. Thus, the efficiency of protein displacement 
(rate and amount of replaced proteins) ultimately modulated cell adhesion, as it is well known that cell-adhesive proteins, 
natural or engineered, adsorbed or covalently linked to materials, facilitate cell adhesion [66, 70]. Currently, the grafting 
of biomolecules (peptides or proteins) is in fact an approach extensively used in tissue engineering to guide cellular 
adhesion and activity [71, 72]. In this case, ligand identity, conformation and density are key parameters when 
developing materials [12, 73] because they regulate the efficiency of integrin-mediated cell adhesion [74], modulate the 
matrix deposition by osteogenic cells [75] and control the cell-type specificity of these responses [76]. 
The last factor related to the surface that should be considered when developing smart artificial materials is the 
ions dissolution that occurs alongside the material resorption [77]. Nowadays, bio- active glasses are one of the materials 
most able to stimulate osteogenesis and angiogenesis due to their ion release ability [78-82]. The dissolution products of 
bioactive glasses (calcium, silicon, titanium, phosphate or another element used as a doping constituent) modify the chemical 
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physiological environment of biological entities, and consequently mediate the cell metabolism. Extracellular Ca2+, for 
example, is known for interacting with bone cells by 
affecting their calcium-sensing receptors (CaSR) and directly activating intracellular mechanisms [83]. Concretely, one 
study per- formed by Honda et al. demonstrated that  extracellular  calcium increases the expression of the insulin-like 
growth factor 2 (IGF-II), which mediates the subsequent increase in human osteoblast proliferation. Other studies revealed 
that cell migration, proliferation and 
differentiation may be controlled by the activation of various CaSR- mediated intracellular signaling pathways [84, 85]. Ca2+ 
is therefore very important for bone remodeling and can be used in scaffolds for 
bone tissue engineering to serve as an extracellular messenger that guides the cell behavior of osteoblastic cell lineage. 
In fact, it is already commonly accepted that ions released from silicon-based bioactive glasses play a critical role in that 
direction. Xynos et al. in 2001 were the first to suggest that ion products of bioactive glass dissolution have a direct 
effect on the gene expression profile of human osteoblasts; more precisely, on genes relevant to osteoblast metabolism 
and bone homeostasis [86]. More recently, an osteogenic glass based on a titanium network has also been shown to act as a 
gene expression regulator able to stimulate the activation of genes involved in angiogenesis [87]. The up-regulation of 
gene expression that can be achieved by the use of bioactive glasses in tissue engineering is thus a very promising 
approach to control cellular activity towards the desired responses. However, it should be stressed that the concentrations 
of these ions is critical, and that the precise control of the material dissolution rate should be required in order not to 
induce cytotoxicity [88]. 
The ion concentration and release kinetics of bioactive glasses can be controlled by the material composition [89] or by 
the fabrication polymer/bioactive glasses constructs [90]. However, in some cases it is still extremely difficult to precisely 
monitor the features of the ion release of the inorganic phase in a predetermined manner, as it is often embedded in the 
organic matrix. This affects the dissolution of the bioactive glass and consequently its ability to trigger the desired cellular 
response (cell adhesion, spreading, proliferation, differentiation and migration) [87, 91]. This problem also affects the 
mineralization potential of the materials [92, 93]. For these reasons, the tailoring of the chemical material surface proper- 
ties is essential. 
 
3.3. Mechanical Properties of Scaffolds 
In addition to the influence that chemical surface properties of a material have on cellular activity, there is significant 
evidence that the other physical properties of the substrates also contribute to stem cell fate determination [94]. 
One of them is the material’s mechanical properties, e.g. its stiffness or elasticity. The local mechanical interactions 
between cells and their microenvironment regulate cell shape, organization and differentiation of the different tissues 
[95, 96] as can be observed in (Fig. 5) [97-107]. This observation is true in the natural environment as well as in artificial 
3D structures. Cells are able to discriminate between different ranges of stiffness in their microenvironment, and to respond 
to this stimulus by pulling on the extracellular matrix. The contractile forces that cells exert on the matrix result in 
tensile stresses in the cytoskeleton. This phenomenon occurs through the transmission of force between the cell and 
the cellular cytoskeleton by means of focal adhesions (cell-extracellular matrix contacts) [13]. The pathway of force 
transmission from inside the cell to the elastic matrix is pro- vided by actin structures that are in turn linked to focal 
adhesions [108, 109], and by well-known signaling proteins such as rho guanosine triphosphatase (Rho GTPase) associated 
with the focal adhesion complexes which act as mechanotransducers [110, 111]. These intracellular forces regulate the 
signaling pathways involved in the fundamental processes that determine cell functions. A very popular study conducted 
with gels by Engler et al. demonstrated that the elastic modulus of the matrix plays a role in directing stem cell lineage 
specifications [4]. Contractile forces in the cytoskeleton are suggested to be driven by actin-myosin action and to regulate 
human stem cell differentiation. Soft substrates mimicking the stiff- ness of the brain tissue induced cell differentiation 
towards a neurogenic lineage, whereas cells cultured on substrates with intermediate and higher stiffness mimicking that 
of muscle and bone tis- sues respectively evolved towards myogenic and osteogenic cells. They also showed that cells 
adjust their internal stiffness to match that of the substrate. Stiffer matrices, in fact, produced stiffer and increasingly 
tense cells. Solon et al. made similar observations with fibroblasts using soft elastic substrates [99]. 
Although it is recognized that the stiffness of materials has an effect on cell behavior, it should be emphasized that 
the stiffness alone does not always seem to be an efficient cell differentiation parameter. For example, Rowlands et 
al. showed that, unlike in Engler and coworkers’ findings, the substrate stiffness alone was not sufficient to achieve 
osteogenic differentiation of mesenchymal stem cells (MSCs) in the stiffness range that they investigated [112]. The 
coating of the gel with biomolecules, such as collagen, fibronectin or laminin, was necessary to induce this phenotype. The 
type of molecules present on the material surface, in fact, modulates the differentiation process for a given substrate 
stiffness.  Their study thus demonstrated that there is feedback between the material stiffness and the adhesive ligand 
as regards osteogenic differentiation. For myogenic differentiation this observation is also valid, but the interplay of these 
two extracellular environmental factors seems to be less obvious. This difference was attributed to a predisposition of 
MSCs to differentiate into myogenic lineage in comparison to osteogenic lineage when cultured on the studied substrates. 
The studies mentioned here thus highlight the difficulties in clearly defining how each material parameter, in an individual 
manner, can be responsible for the triggering of a specific cell phenotype. Such assays often lead to controversial discussions 
because the conditions in which the material is investigated usually differ from one study to another (cell type used, cell 
badge, parameters set for the assay, material conditioning, etc). Nevertheless, it is commonly accepted that, whether 
combined with other factors or not, a material’s mechanical properties play an important role in the de- termination of cell 
behavior. This is particularly clear when looking at the numerous studies reported in the literature on cells and 
mechanosensing, mechanotransduction and mechanoresponse [95, 111, 113]. 
 
 
 
Fig. (5). Stiffness of several different healthy tissues (notice elastic modulus is in logarithmic scale). [4,97–107] On the bottom, 
typical substrate materials used for cell culturing. Polyacrylamide (PAM); Polydimethylsiloxane (PDMS); Polystyrene (PS). 
 
 
4. COMPOSITE MATERIALS AND HYBRIDS FOR BONE REGENERATION 
In bone regeneration since the 80s [114], composite materials are usually made by associating an organic phase with an 
inorganic one. This combination is an interesting approach for scaffold fabrication, as the nature of the selected constituents 
resembles the structure of natural bone. The organic part can mimic the collagen and the glycosaminoglycans (GAG) present 
in the extracellular matrix, while the inorganic one can mimic the bone mineral phase. The aim is that the global properties 
of the scaffold are supported by both constituents [115, 116]. A typical example of a composite is a scaffold prepared by 
incorporating hydroxyapatite (HA) granules or fibers in a polymeric matrix [117-122]. Such studies reveal, how- ever, 
that the contents of the inorganic and organic phases directly influence the bioactivity and mechanical properties of the 
scaffolds. In many cases, a template that is efficiently bioactive often has weak mechanical properties [93]. Thus, a 
compromise should be found when developing composites in order to obtain a suitable balance between the two properties, 
considering too that inorganic compound shape, size, dispersion, orientation and mechanical features also play a role [115]. 
Furthermore, the scaffolds should have an appropriate structure with interconnected pores to enable cell attachment, 
migration into the scaffolds, and fluid and blood vessel infiltration [15, 123, 124]. Interestingly, composites can be shaped 
with diverse architectures and with different porosity [15, 90]. This is possible thanks to the various processing technologies 
currently available, such as solvent-casting and particulate leaching techniques, gas foaming, rapid prototyping and 
electrospinning. 
Another parameter that is also crucial to the scaffold’s final properties is the interaction between the organic phase 
and the inorganic one [125]. Composites commonly prepared with micro-sized inorganic particles by conventional melting 
processes, for example, do not have a direct interface between their compounds (Fig. 6). This may be caused by the 
manufacturing process used to prepare the material (such as, for example, a drawing method that may be responsible for 
the formation of a void between the compounds [93] (Fig. 6a), and/or non-optimal affinity between the compounds [126]  
(Fig.  6b)). Usually, nanosized inorganic compounds  are therefore preferred for preparing composites (nanocomposites), 
because an enhancement in the interfacial interactions between the phases can be easily achieved [127]. Indeed, the 
number of inter- faces is increased due to the high surface area provided by nanoscaled compounds, which can lead to 
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better control of the mechanical and degradation properties. However, this strategy is not completely optimal, and the 
probability of crack initiation- propagation may be high due to these numerous interfaces. This may result in an ultimate 
depreciation of the mechanical properties [115, 128]. To avoid this and also a possible phase segregation [129], 
polymer/inorganic nanofiller compatibility is often improved by modifying the surface with organic molecules or 
surfactants [130, 131]. Despite this, the synergy between the two phases is still often inappropriate for the targeted 
application because of the heterogeneous degradation of the phases, the rapid loss of the composite mechanical properties, 
or the inappropriate release rate of ions/monomers from the material [93, 132]. Hence, composite materials with 
interactions at the molecular or nanometric level (also called hybrid materials) have been developed in order to produce 
more homogeneous templates with improved properties for bone regeneration (superior mechanical properties, 
homogeneous degradation and synergistic material). The fabrication of such materials usually involves a common versatile 
technique: the sol-gel method [133]. This method allows the manipulation of the nanostructure of the materials at the 
molecular level and the control of the nature of the interfaces. Thus, it is a very powerful tool to develop hybrids. 
 
4.1. Hybrid Materials 
Hybrids are classified into two categories depending on the nature of the intimate organic-inorganic interface [114, 
129, 134, 135]. The first family is class I materials, which possess weak inter- actions between constituents (Van der 
Waals, electrostatic or hydrogen bonding interactions). The second is class II materials, which exhibit strong interactions 
between components (covalent or ionic bonding). Compared to traditional composites, hybrid scaffolds prepared with 
weak or strong phase interactions usually pre- sent better properties, but a clear difference in the resulting proper- ties 
of the scaffold is noted between these two classes of hybrids, however (see a summary in Table 1). 
4.1.1. Hybrids Class I 
Hybrid organic-inorganic materials of class I have been extensively investigated up to now for numerous applications. 
The interpenetration of the organic and inorganic networks constitutes the basis of these materials and explains why 
class I hybrid scaffolds exhibit improved mechanical and degradation properties when compared to traditional composites. 
In these materials, the two phases are nanoscopically separated but macroscopically uniform [136]. 
 
 
Fig. (6). Typical examples of composites that possess limited intimate interactions between their inorganic constituent (microparticles) 
and polymeric matrix. Arrows point the presence of voids between the phases (material shown on picture a: extruded and drawn material 
– material shown on picture b: extruded and compressed material). (picture a is adapted from [93] and picture b from [126] with 
permissions). 
 
Regarding bone tissue engineering, a representative example is the material developed by Martin et al. in 2004 [19]. 
Polyvinyl alcohol (PVA) was chosen for the organic part and bioactive glass for the inorganic one. They incorporated PVA 
during the synthesis of the bioactive glass, which was prepared by the sol-gel method. After gelation of this hybrid sol 
and an aging-drying process, class I hybrid monoliths were obtained. The study revealed that by control- ling the 
experimental conditions, crack-free monoliths could be produced. The degradation as well as the bioactivity of the materials 
could be also tailored by changing, for example, the content of PVA, or adding extra-compounds in the initial glass 
composition 
(P2O5 in CaO-SiO2 system). In their study no mechanical tests were performed, but another report by Landry et al. showed 
that organic- inorganic materials prepared by the in situ polymerization of silanes (tetraethylorthosilicate TEOS) in polymers 
resulted in  materials with enhanced mechanical properties [137]. This was attributed to the nature of the interactions 
between the two phases: the hydrogen bonds formed between the residual hydroxyls of the hydrolyzed TEOS molecules 
and the ones in the polymer, which acted as crosslinkers [138]. However, this kind of bonding is rather weak and is not 
stable in aqueous medium, as the water molecules may easily separate the chains [139]. For this reason, the degree of 
crosslinking and interpenetration of the phases is very important. If the nature of the precursors is not properly 
considered, and if the conditions of the hydrolysis reaction are not well controlled, the crosslinking and phase 
interpenetration may not be sufficient to tailor the degradation of the material efficiently. In the case of a fast 
degradation might not be suitable to support bioactivity, for example [19]. Another drawback for the production of these 
materials is the phase separation that might occur due to incompatibilities be- tween the phases. Once again, reaction 
conditions such as temperature and pH are of paramount importance to accomplish a homogeneous material, and this should 
be precisely controlled [137]. Al- though they do have some drawbacks, class I materials are promising considering the 
overall properties they can exhibit if their de- sign is properly tailored. 
The last example has been published recently. Similar to ormosils, ormoglasses are organic modified glasses; in other 
words, organometallic oligomer or polymer chains with no apparent order. They share some properties of pure inorganic 
compounds, such as hydrophylicity and ion release, but offer further features such as a positive charge, which improves 
interaction with some negative biodegradable polymers such as PLA, and more flexibility [140]. The calcium and phosphate 
included in their formulations are linked to the ormoglass rather than being encapsulated as a salt, suggesting that a 
more sustained release to enhance osteo- and angiogenesis can be achieved. 
4.1.2. Hybrids Class II 
An increasing effort has been made in recent years to produce class II materials to overcome the problems resulting 
from weak interactions between the material phases. The aim is to produce scaffolds with a good stability and a good 
performance under physiological conditions. Nevertheless, such materials are difficult to produce, and few involving 
biocompatible and biodegradable polymers have been reported in the bone regeneration literature. Normally, they imply 
the use of coupling agents to functionalize the polymer in order to covalently link the polymer to the inorganic part (a 
pure silica network or silica network with incorporated calcium and CaP-ormoglasses) [141-144]. Considering that there are 
only a few examples of class II hybrid materials in the literature and that they show a high promising potential for the 
field, each one is briefly presented here. 
The first family of materials (disc shape) was developed by Tian et al. in the 90s [141]. This material was a 
polycaprolactone (PCL)/silica hybrid prepared by the sol-gel method, in which PCL was intimately incorporated into a silica 
network produced by condensation of TEOS. The reaction consisted of the end-capping of hydroxyl PCL with 
isocyanatopropyltriethoxysilane (IPTES). The terminal hydroxyl groups of the polymer reacted with the isocyanate 
group of IPTES to form a urethane linkage, creating an IP- TES end-capped PCL. After the substitution of the ethoxy 
ligands of IPTES by hydroxyl groups (hydrolysis), IPTES end-capped PCL condensated and linked to hydrolyzed TEOS 
molecules. As a result, a silica network containing polymeric fragments was created, in which IPTES acted as an 
intermediate covalent linker between the two phases. The reaction extent was mainly controlled by the molecular weight 
of the PCL as the length of the PCL chains directly influenced the number of available sites for reaction [145]. 
Consequently, the shorter the chains, the higher the number of available reactive terminal groups, and the higher the 
end-capping potential. Apart from the covalent bonding, these hybrids were shown to be packed due to hydrogen bondings: 
PCL ester groups interacted with the residual hydrolyzed ethoxyl groups of the silica network [145]. These two types of 
interactions contributed to the good stability of the polymeric phase in hybrids in comparison to pure PCL [145]. In addition, 
according to preliminary tests [146], it was shown that these hybrids were also a suitable support for fibroblast cell 
cultures. 
Several years later, Rhee et al. incorporated calcium (CaCl2) in the system, with the aim of improving the hybrids’ 
bioactivity [147- 149]. This was a very interesting idea, as calcium ions (Ca2+) play an important role in the bioactivity 
efficiency of materials and the osteogenesis process. Later, Rhee published a more detailed study in which he assessed 
the bone-like apatite-forming ability of this end-capped PCL/silica/calcium material depending on the PCL content in the 
hybrids [150]. Hybrids containing the lowest PCL content exhibited the best bioactive properties. This was explained by 
the presence of a higher number of silanol groups in the silica phase for the low PCL content hybrids and a stronger 
release of Ca2+ into the simulated body fluid (SBF) solution [148, 150, 151]. Indeed, it is well reported that silanols act 
as nucleation sites for apatite crystals, and Ca2+ ions released in the surrounding medium contribute to the supersaturation 
of the fluids and the deposition of a calcium phosphate precipitate [152, 153]. The study showed that the PCL content 
also affected the mechanical properties of the materials, but all the materials possessed tensile strengths and Young’s 
moduli in the range of trabecular bone. Moreover, in vivo tests revealed that the material directly  induced bone formation 
on the surface of the scaffold without creating any fibrous tissue [151]. 
The second family of materials (porous) was  developed by Poologasundarampillai et al. in 2010 [142]. They functionalized 
a biopolymer, poly(y-glutamic acid) (yPGA), with glycidoxypropyltrimethoxysilane (GPTMS) and used TEOS to create the 
inorganic network, adding calcium into it (CaCl2). Although synthetic polymers such as PCL or PGA degrade by random chain 
scissions from the bulk and rapidly affect the mechanical properties of the material, the natural yPGA degrades 
enzymatically from the surface. This means that the bulk of the material can maintain its mechanical properties as long as 
water does not infiltrate the matrix and catalyze the inner degradation. It was thus expected that the use of yPGA 
. 
 
would slow down the loss of the scaffold’s mechanical integrity. But the degradation process is a complicated phenomenon, 
whose rate and mechanism is influenced by numerous factors (porosity, hydrophilicity, pH of surrounding fluid, etc). As no 
direct study has been performed to assess the loss of mechanical properties and the role of yPGA, it is not possible, 
however, to certify that yPGA is an effective compound for better control of the material degradation of class II hybrids.  
However, one of their complementary studies revealed the role of the degree of crosslinking in the dissolution time of 
the polymer [154]. Hybrid materials with a high degree of crosslinking exhibited a slower polymer release than ones prepared 
with a lower covalent coupling. As reported in their first synthesis study, the coupling of the two materials can be tailored 
by the amount of coupling agent used for reaction: a higher proportion of coupling agent resulted in an increase in the 
organic/inorganic interactions. On the other hand, they demonstrated that the amount of solvent used in such reactions 
impacts the reaction rate, the nanostructure and the nanoporosity of the materials. As for the end-capped 
PCL/silica/calcium material, these hybrids exhibited good bioactivity, as calcium ions have been pointed out as essential for 
the formation of the hydroxyl carbonated apatite. The incorporation of calcium in the network was there- fore required to 
promote bioactivity. Knowing that a high degree of crosslinking in the hybrids leads to more compact structures and 
consequently a relatively slow dissolution rate of calcium, the working reaction conditions should be carefully selected in 
order to reach a proper bioactivity. About mechanical properties, compresive mechanical tests demonstrated that the 
toughness of the hybrids was improved, in comparison to glass alone. Finally, cellular assays (live/dead test) showed that 
Saos-2 [155] lineage cells attached and spread on the material surface without suffering any cytotoxic effects. 
The third family of materials (foamed structure) was developed by Mahony et al. in 2010 [143]. It is also prepared 
with a bio- polymer (gelatin) and (3-Glycidoxypropyl)methyldiethoxysilane (GPTMS). TEOS was also used to form the 
silica network but the materials did not contain calcium. The main aim of this study was to demonstrate that tough 
materials could be created by preparing class II materials. As for the previous materials, the study showed that the 
percentage of gelatin and degree of crosslinking affected the mechanical properties of the scaffolds. The degree of 
porosity was influenced by the concentration of surfactant used during the material foaming. This globally impacted the 
mechanical strength of the scaffolds. All materials produced were considered stiff substrates, based on the approximate 
stiffness of various tissues. In addition, they had remarkable elastic properties and tailorable dis- solution properties. 
Finally, according to cell morphological observations (mesenchymal stem cells (MSCs)), the materials were shown to be 
biocompatible and non-cytotoxic independently of the precursor reagent content or the chemical control performed on 
the reactions (degree of crosslinking and amount of surfactant). 
The fourth family of materials (fibrous structure) was recently developed by Sachot et al. [144]. An ormoglass was 
covalently linked to a degradable polymer (polylactic acid; PLA). Based on the sol–gel method and a succession of surface 
treatments, they successfully coated hollow electrospun PLA fibers with a silicon CaP based ormoglass (Fig. 7) using 
aminopropyltriethoxysilane (AP- TES) as coupling agent. This approach allowed a direct interaction of the bioactive phase 
with cells, as well as controlled release of the ions. Rat MSCs cultured on these fibers showed good cell spreading and 
excellent interactions with the material. Moreover, the coated electrospun mat was remarkably flexible [144]. In 
addition, the protocol can be transferred to other structures and ormoglasses, thus allowing the fabrication of various 
materials with well-defined features and offering a large range of possibilities for the development of scaffolds for 
numerous applications. 
Although the hybrids described above seem to be the only class II materials found in the literature, it should be 
noted that other materials may also emerge in the next few years. Maeda et al., for example, have already achieved the 
first step of polymer functionalization with PLA and APTES as coupling agent [156]. However, they did not exploit this 
finding to create a real organic/inorganic material in which the functionalized polymer is intimately incorporated in a 
silica network; rather, the material was simply formed through the reaction of functionalized PLA chains with other 
functionalized PLA chains. No reagent such as TEOS was used to intro- duce a high content of inorganic network in the 
hybrid. 
 
                               
Fig. (7). Ormoglass coated fibers adapted from [144] with permission a) average diameters of hollow nanofibers coated with ormoglass. 
b) FE-SEM image of their surface. c) rMSCs adhered to coated fibers. d) flexibility of the tissue at the macroscale. 
 
Therefore, the inorganic content was restricted to the quantity of APTES molecules efficiently linked to the PLA chains, 
and only molecular weight was a valid variable to modulate final results. From a general point of view, this material could 
be considered as a class II hybrid because it possesses a strong covalent bond between its organic and inorganic phases. 
However, it does not exactly fit into the category, because no inorganic network was really introduced in the material (except 
the part of the APTES organosilane). For this material, classification is rather subjective and controversial [139, 157]. Some 
scientists might already consider it a class II material, while others may not. In any case, such functionalized polymers 
might be the starting point for the production of additional class II hybrids in the future, as it has been the case for the 
GPTMS functionalized gelatin prepared by Ren et al. [157, 158] in 2001 and the subsequent work described above, performed 
by Mahony et al. in 2010. 
Finally, there are several approaches involving strong mineralization of porous constructs such as hydrogels. One example 
of innovative alternatives are the scaffolds developed by Douglas et al. [159] They mineralized porous constructs by 
enzymatic routes (alkaline phosphatase (ALP)-induced enzymatic mineralization) in- stead of conventional SBF immersion. 
In this way, they achieved the deposition not only of CaP but also magnesium phosphate (MgP), a well- known CaSR agonist 
[87, 160]. The results were crystalline and amorphous calcium deficient hydroxyapatite (CDHA) mineralized gellan gum 
(GG) mimicking natural bone. 
Further efforts should be done in order to have the possibility to perform clinical studies once in vivo models and relevant 
results are trustworthy, and adapted to the nature of these types of nanostructured hybrid scaffolds. This step however, 
as far authors know, still did not arrive. 
5. COMMON SCAFFOLD PROCESSING METHODS 
5.1. Electrospinning 
Among the various fabrication methods available to produce 3D scaffolds, electrospinning is one of the most used 
techniques nowadays, in spite of its inherent difficulties to create macropores for cell migration. It is based on 
electrostatic principles and enables the deposition of micro and nano-scaled fibers. The main benefit of producing 
electrospun fibrous substrates is being able to mimic the nanofibrous structure of the collagen ECM [9, 22, 161]. It is, 
moreover, a cost-effective technique that does not require sophisticated equipment and which can be used with an impressive 
variety of compounds [161, 162]. The set-up consists of a syringe pump, a voltage source and a metallic collector (Fig. 8a). 
The principle be- hind the formation of fibers relies on the competition between the electrostatic forces formed in a 
polymeric slurry (melt [163] or solution [22]) when it is subjected to a high voltage, and its surface tension. When a 
voltage on the tip of the syringe is sufficiently increased up to a critical point, repulsive forces overcome the surface 
tension and a liquid jet rises from the drop (the appearance of a Taylor cone [164]). The further the jet travels from the 
drop, the thinner and more elongated it becomes. This occurs because of the instability of the jet, which starts to whip 
and then bend and stretch [165-167] (Fig. 8b). During this whipping process, the solvent evaporates, and solidification of 
the jet occurs. Fibers are then collected on a grounded metallic support. The flying time of the jet should thus be long 
enough to enable its complete drying out. Fibers are deposited either as random or aligned mats, by using immobile or 
rotary collectors respectively [168, 169]. 
a) b) 
 
c) d) 
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Fig. (8). a) Scheme representing the electrospinning set-up. b) Path of an electrospinning jet that undergoes bending instabilities, 
solvent evaporation and slimming. (image adapted from [167] with permission). 
 
As regards biological concerns, composite electrospun fibers are the most interesting materials. In fact, bioactive 
compounds are generally added in the polymeric solution to provide bioactivity to the organic substrate [170]. To do so, 
bioactive nanoparticles are frequently used. They are incorporated in the polymeric solution before starting the 
electrospinning. Typically, these nanoparticles are hydroxyapatite or silica xerogels [171-173]. Due to their high surface-
to-volume ratio, these composites usually show good cellular adhesion and activity [22, 162, 174]. As explained previously, 
the nanotexture (i.e nano-roughness induced by the nanosized fibers) that provides such electrospun fibers is particularly 
attractive for cells. They are also particularly interesting as they have been demonstrated to promote mineralization. 
However, this is not al- ways the case for all of the nanocomposites. Some possess limited bioactivity or cellular responses 
due to a common critical problem: the bioactive phase is embedded in the polymer. Consequently, at early stages this 
phase is not detected by cells, nor does it contribute to the supersaturation of bioactive ions at the interface of the bio- 
material and the biological environment, a mechanism necessary to induce calcium-phosphate precipitation which is also 
involved in cell signaling [77]. An interesting study by Tong et al. demonstrated that the exposition of the particles 
can be controlled by changing the size of the nanoparticles and by precisely controlling the experimental parameters of 
the electrospinning process using an in situ coupled ultrasonic probe for dispersion of the nanoparticles [92]. However, 
even though researchers seem to be aware that the encapsulation of the bioactive phase is a critical issue, very few 
studies that focus on that problem are found in the literature. To overcome this challenge, as well as the limitations 
related to conventional composites (inhomogeneous degradation rate of the com- pounds, very low or inexistent cohesion 
between them and limited strength), hybrid organic-inorganic fibers prepared by the sol-gel method have attracted 
more interest in the last five years. Song and coworkers were, for example, some of the first to introduce this concept 
in bone tissue engineering and electrospinning [175]. In 2008, they reported the development of gelatin-siloxane 
nanofibers produced with intimate interactions between their compounds (hydrogen bonding). The siloxane introduced in 
the gelatin acted as a bridging agent for the polymer chains and resulted in a crosslinking effect. The fibers exhibited a 
good stability and were able to form bone mineral, and were also able to efficiently support cell adhesion, spreading and 
proliferation, as well as enhancing osteoblastic activity. This hybrid appeared to be a promising material for bone 
regeneration. This study thus highlighted the potential of the sol-gel technology to prepare hybrid scaffolds using 
electrospinning and the necessity to produce a synergic hybrid blend. In this way, scaffolds with remarkable properties 
can be produced. However, in comparison to the nanocomposites approach, hybrid fibers have not attracted the attention 
of many research groups. 
5.2. Rapid Prototyping 
Rapid prototyping (RP), or solid freeform techniques, involves several methods for scaffold processing and have become 
very popular in bone regeneration in recent years. RP is one of the few methods that can provide similar mechanical 
properties to trabecular bone while maintaining a high level of porosity. This technique basically consists of the physical 
reproduction of a computer- generated design [176] and the depositing of a precursor slurry. The deposited wall can be 
the result of a melt or a polymer solution containing a dispersed inorganic phase, with the dispersion of an inorganic 
phase into a polymer matrix being the most common approach for RP to date. However, this strategy presents drawbacks 
similar to the slurries prepared for electrospinning, i.e. phase masking, heterogeneous dispersions, poor polymer/inorganic 
phase interaction. Nevertheless, the advantage of rapid prototyping is the fabrication of scaffolds with a higher 
mechanical resistance and macroporosity (in comparison to electrospinning). Minimum wall thicknesses are at around the 
tens of microns, which can also induced an undesired diffusion-controlled degradation. Recently, RP has been combined 
with electrospinning, which seems to give good results [177] highlighting thus the potential of associating different 
techniques together. 
5.3. Solvent Casting/Particle Leaching 
This simple technique has had good results in tissue engineering, as it combines a good interconnection between pores, 
and high porosity (around 90-95%); however, the resulting mechanical properties are far to be similar to bone. It basically 
consists of the dispersion of an inorganic phase in a polymer solution, which also has a homogeneously dispersed aqueous-
soluble porogen. Once the solvent is evaporated after casting the slurry into molds, the solid piece is immersed in water 
to dissolve the porogen and produce pores [80]. However, the wetting of the particles should be improved for optimized 
mechanical properties. Several approaches can be found in the literature, with excellent results [170, 178]. 
 
5.4. Freeze-drying 
Freeze-drying, or lyophilization, is a way of producing porous scaffolds that involves the sublimation of the solvent in 
a polymer solution through the decrease of temperature and pressure under the triple point. With this process, a high 
level of porosity is achieved [170], and this versatile process can easily be tuned. For example, unidirectional freeze-
drying allows the texture and alignment of porosity, improving pore interconnection [179]. The amount of porosity needs 
to be higher than 95% and mechanical properties are, as in some types of bone, anisotropic. In this case, to produce 
hybrid materials, a slurry solution of polymer and  an  inorganic constituent are usually uniaxially frozen using a thermal 
gradient with liquid nitrogen, and then placed in high vacuum for hours or days. Combinations are multiple, especially in 
bone regeneration [180]. 
 
5.5. Foaming 
Foaming, one of the most common methods to produce macro- porous scaffolds, uses chemical (surfactants) or physical 
porogens (H2O2, mixer, supercritical CO2 [181]) to improve cell migration. However, the problem of pore connection still 
needs to be solved, as the neck is usually not big enough for cell migration and colonization. Several examples can be 
found involving class I hybrid embedded in a polymer matrix, with uneven results [182, 183]. Another problem is the 
lack of mechanical resistance, which is inherent to the level of porosity, but this can be solved by polymer reinforcement 
[118]. 
 
Table 1. Summary of different hybrid scaffolds for bone regeneration. 
 
Inorganic Phase Organic Phase Hybrid Class Relevant Features Process Method Refs 
CaO–SiO2 
CaO–SiO2-
P2O5 
 
Polyvinyl alcohol (PVA) 
 
I 
 
Crack-free monoliths can be produced 
 
Casting 
 
[19] 
 
 
 
In situ polymerized 
silane 
poly(methyl methacrylate) 
(PMMA) poly (vinyl acetate), 
poly 
(vinyl pyrrolidone) 
poly (N,N-dimethylacrylamide) 
 
 
 
I 
 
 
Enhance mechanical properties 
and degradation 
 
 
 
Casting 
 
 
 
[137,138] 
 
 
Si-Ca-P ormoglass 
 
 
Polylactic acid (PLA) 
 
 
I 
Introduction of Ca and P in an 
organometallic network with similar 
nature as polymer ma- trix. Higher 
flexibility 
 
 
Electrospinning 
 
 
[140] 
Hydroxiapatite 
(HA) 
nanoparticles 
Polylactic acid (PLA) and 
collagen type I 
 
I 
Enhance proliferation and 
mineralitzation in human fetal 
osteoblasts (hFob) cells 
 
Electrospinning 
 
[171] 
Carb n te nano- 
hydroxyapatite 
(CHA) 
 
Polylactic acid (PLA) 
 
I 
Enhance viability and 
mineralitzation in normal human 
osteoblasts (NHOst) 
 
Electrospinning 
 
[173] 
 
Carbonate nano- 
hydroxyapatite 
(CHA) 
 
poly(hydroxybutyrate-
co- hydroxyvalerate) 
(PHBV) 
 
 
I 
Av id nanoparticle agglomeration by 
ultra- sonic proble coupling. Enhance 
mineralitza- tion in human osteoblast 
cells (SaOS-2) 
 
 
Electrospinning 
 
 
[90] 
 
 
Siloxane and CaCl2 
 
 
gelatin 
 
 
I 
First organometallic network being 
combined with a polymer. Better 
stability than pure gelatin fibers. 
Enhance of mineralitzation in murine-
derived preosteoblast MC3T3-E1 
 
 
Electrospinning 
 
 
[175] 
 
HA nanoparticles 
 
PLA 
 
I 
91-96 % of interconnected porosity 
with a maximum compressive modulus 
of 123 kPa. 
Supercriti
cal 
foaming 
 
[181] 
. 
 
HA nanoparticles or 
B- tricalcium 
phosphate (B- TCP) 
 
 
PLA 
 
 
I 
 
No chronic inflammation on Sprague-
Dawley albino rats in vivo 
assays 
 
Supercriti
cal 
foaming 
 
 
[183] 
 
 
SiO2 and IPTES 
 
Low molecular weight 
polycaprolac- tone 
(PCL) 
 
 
II 
IPTES end-capped PCL covalently 
linked to SiO2 network; good stability 
against degrada- tion 
 
 
Casting 
 
[141,145,1 
46] 
Hydroxyapatite (HA) 
induced by a IPTES- 
SiO2 network +CaCl2 
 
Low molecular weight 
polycaprolac- tone 
(PCL) 
 
 
II 
 
Better HA precipitation induced by 
Ca2+ ion release 
 
 
Casting 
 
 
[147–151] 
glycidoxypropyl 
trimethox- ysilane 
(GPTMS) - SiO2 
network +CaCl2 
poly(y-glutamic acid) (yPGA) 
 
 
II 
yPGA enzymatically degrades from 
the surface and maintain mechanical 
properties. 
 
 
Casting 
 
[142,154,1 
55] 
glycidoxypropyl 
trimethox- ysilane 
(GPTMS) - SiO2 
network +CaCl2 
 
 
Gelatin 
 
 
II 
 
Able to integrate calcium in the 
network and tailor stiffness by the 
degree of crosslinking 
 
Foaming 
and Freeze-
Drying 
 
 
[143] 
Si-Ca-P ormoglass-
(3- Aminopro- 
pyl)triethoxysilane 
(AP- TES) 
 
 
High molecular weight Polylactic 
acid (PLA) 
 
 
II 
 
Ormoglass coated electrospun fibers. 
Able to maintain mechanical properties 
when degrade and to show bioactive 
phase directly to cells 
 
 
Electrospinning 
 
[144] 
 
Calcium deficient 
Hy- droxyapatite 
(CDHA) 
 
 
Gellan gum (GG) 
 
 
II 
Alkalin  phosphata e (ALP)-induced 
enzy- matic mineralization using 
calcium phosphate and magnesium 
phosphate as precursors 
 
 
Casting 
 
 
[159] 
 
6. SOFT TISSUES 
The incorporation of hybrid materials in tissues other than bone is still at an embryonic stage (see Table 2), but skin is 
one tissue whose researchers are beginning to incorporate hybrid materials into their studies [184]. Skin is not a 
simple structure, but rather a very hierarchical distribution of several strata, which covers and protects the body; as 
with bone, skin wounds are sometimes too big for the body to repair by itself. The epidermis, formed by flattened epithelial 
cells distributed in layers, forms the outer part of the organ. The dermis, just under the epidermis, is basically composed 
of fibroblasts and dense connective tissue. Here biological entities such as receptors, hair follicles, nerves, blood 
vessels, muscles, ligaments and different glands can be found. However, the first materials used for major skin 
damage do not aspire to regenerate such a complex system. The minimum requirements for a regenerative wound dressing 
are: a proper seal to avoid the entry of bacteria, and capability to allow the diffusion of oxygen, water, nutrients and 
residues. Applications for such wound dressings include serious burns, ulcers (diabetic or pressure-derived) or traumatic 
accidents [185]. Currently, the options available are mainly salts dispersed in a polymer matrix or forming hybrid structures 
that act as crosslinkers of the same polymer matrix, such as alginates. Antibacterial agents can also be incorporated 
into the material to prevent infection; one example is alginates mixed with chitosan and silver nanoparticles acting as the 
antibacterial agent [186]. Another interesting approach is to enhance the bioavailability of thrombin, a coagulation 
agent particularly relevant in skin care as it is the result of the hemostatic response and is essential for the conversion 
of fibrinogen to fibrin, a process involved in wound regeneration, by conjugation with iron oxide nanoparticles (y-Fe2O3) 
[187]. The acceleration of the regenerative process was confirmed by analyzing the tensile resistance of wounds in vivo. 
Other materials such as nitrite-containing glassy ormosils (siloxanes) mixed with chitosan and polyethilenglycol (PEG) 
provide efficient nitric oxide (NO) release matrices. NO has been demonstrated to be an efficient anti- bacterial agent 
and vasoactivity modulator as well as angiogenic stimulator, making it a good promoter of wound healing [188]. In addition, 
and similarly to bone regeneration, collagen-supporting calcium phosphate nanoparticles have been shown to be efficient 
agents in treat wound healing thanks to their controlled release of ions [189]. 
 
 
 
Table 2. Summary of different hybrid scaffolds for soft tissue regeneration. 
 
Inorganic Phase Organic Phase Hybrid Class Relevant Features Process Method Refs. 
Skin regeneration 
Silver nanoparticles Chitosan I Antibacterial properties Freeze-drying [186] 
 
y-Fe2O3 nanoparticles 
Bovine serum albumin (BSA) 
+ Thrombin 
 
I 
Enhance the bioavailability of thrombin for 
better coagulation 
 
Mixing 
 
[187] 
 
Nitrite-containing 
siloxane 
Chitosan and 
polyethilenglyco
l (PEG) 
 
I 
Provide nitric oxide (NO) as antibacterial 
agent and vasoactivity and angiogenic 
stimulator 
 
Casting 
 
[188] 
Calcium glycerol 
phos- phate 
nanoparticles 
 
Collagen 
 
I 
Release calcium ions to the media improving 
angio- genesis and wound healing. 
 
Casting 
 
[189] 
Cartilage regeneration 
Calcium salts Alginate or hyaluronic acid I Achieving 80% new cartilage Casting [193,194] 
 
Glycerol phosphate 
 
Chitosan + blood 
 
I 
Enhance material sealing, number of cells and 
collagen production. 
 
Casting 
 
[195] 
amorphous calcium 
phos- phate (ACP) 
particles 
PLA + fibroblast growth 
factor (bFGF) 
 
I 
Successfully resurface the defect with new 
cartilage and restore the subchondral bone 
in a rabbit model 
 
freeze-drying 
 
[196] 
Nerve regeneration 
 
 
Carbon nanotubes 
(CNTs) 
 
 
Collagen 
 
 
I 
Effective in providing a global guidance for 
neuron behavior, improving differentiation 
and growth cones with appreciable 
microspikes and filopodia. 
 
 
Casting 
 
 
[201] 
Muscle regeneration 
multi-walled carbon 
nano- tubes 
(MWNTs) 
 
gelatin 
 
I 
Efficient alignment and differentiation of 
myoblasts to offer functional 
myotubes 
 
Electrospinning 
 
[202] 
 
Cartilage is considered a non-vascular tissue, as the blood sup- ply is limited, and nerve and lymphatic vessels are scarce; 
in this way it shares some similarity with the osteoid. It is also a tissue that is not easily regenerated by itself. The human 
body involves three types of cartilage: elastic, fibrous, and hyaline (articular), which is the one that has invited the most 
research to date [185, 190, 191]. It is composed by an ECM formed by mainly collagen II fibers (~60% dry weight), 
proteoglycans, and chondrocytes (1% of the total volume distributed in small colonies). It provides a high compressive 
resistance and a low coefficient of friction, and its functions are related to the smoothing of the synovial joint displacement. 
The 25- 35% dry weight component is made up of proteoglycans that include hyaluronic acid, chrondoitin sulphate, keratin 
sulfate and dermatan sulfate [185]. 
Arthroplasty is the most common way of replacing a joint, but has associated risks and side effects. The bottom area 
of the articular cartilage is calcified as protection from the bone [185]. Thus, promising hybrid materials to replace 
cartilage include those comprising a combination of alginates or hyaluronic acid with calcium salts [192]. Good results were 
obtained in subcutaneous implantation: 3D shape conservation in mice and sheep, achieving 80% of new cartilage [193, 194]. 
Chitosan hydrogels, glycerol phosphate and blood combinations are also an interesting option [195]. Successful resurfacing 
of the defect with cartilage and restoration of the subchondral bone in rabbit was also achieved by an amorphous CaP/PLA 
scaffold loaded with basic fibroblast growth factor (bFGF) [196]. 
Nerve regeneration is another area in which hybrid materials, especially conductive ones, are beginning to be used. The 
nervous system is extremely complex, and comprises the central nervous system (CNS) and peripheral nervous system 
(PNS). The functional units are neurons which have lost their ability to divide. In this case, the topography of constructs is 
focused on aligned shapes. The need for electrical stimulation makes carbon nanotubes (CNTs) and their derivatives an 
interesting option. For example, a fibrous combination of a biodegradable polymer with CNTs and graphene offer an 
alternative for the regeneration of the damaged central nervous system (CNS) [197-200], as does a combination with 
collagen [201]. 
Muscle tissue engineering needs the fabrication of packed, dense, aligned and mature myotubes [202]. Multi-wall 
nanotube (MWNT)-gelatin hybrid fibers were produced by electrospinning, and allowed the efficient alignment and 
differentiation of myoblasts to offer functional myotubes. However, a controversy still exists about the biodegradation 
of carbon nanotubes and their derivatives [203]. 
 
 
7. CONCLUSION 
Hybrid materials seem to be valuable systems for bone tissue engineering due to their biodegradable constituents, 
remarkable bioactivity, good mechanical properties and excellent effi- ciency/cost ratio. The possibility to tune the 
material structure (foams, discs, fibers or 3D constructs with different porosity) and properties (stiffness, bioactivity, 
topography) by controlling the material preparation (chemical reactions and reagents contents) is a great advantage, as  
different applications require materials with different properties, and material design could be adapted to a specific 
. 
 
application. However, only preliminary assays have been per- formed in vitro and in vivo to demonstrate the biocompatibility 
of the structures outside the field of bone regeneration. Nanostructuration of hybrid II biomaterials is the natural trend, 
and few examples are found. No extensive studies seem to have been performed to evaluate in more detail the adhesion, 
proliferation, differentiation and potential of these scaffolds to trigger specific cellular responses. To further advance 
towards clinical trials, proper in vitro and in vivo models shall effectively demonstrate that these materi- als efficiently 
promote osteogenesis (bone) and angiogenesis (bone and rest of tissues). In this way, they could definitely be confirmed 
as promising grafts, not only for bone regeneration but also for other tissues applications such as skin, nerve, cartilage 
etc, where they are still in an embryonic state, but growing. But such materials represent a relatively new concept in 
biomaterials, and their development is just beginning. Other approaches will be performed in the future using diverse 
polymers, coupling agents and inorganic phases, which will require extensive studies in the next few years to uncover the 
cellular responses induced by these materials. 
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